| Name: | Apremilast Impurity 4 |
| Catalogue No. | VE008012 |
| CAS No. | 1407140-51-5 |
| Molecular Formula | C20H32N2O6S |
| Molecular Weight | 428.5 g/mol |
| Status | In-Stock |
| IUPAC Name | (S)-2-acetamido-N-((S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-4-methylpentanamide |
| Description | Apremilast Impurity 4 (CAS NO.-1407140-51-5) IUPAC Name-(S)-2-acetamido-N-((S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-4-methylpentanamide. Apremilast is an oral phosphodiesterase 4 inhibitors that have an impact on a wide range of inflammatory mediators involved in psoriasis and psoriatic arthritis, this is the novel treatment that focuses on maintaining a balance between pro-inflammatory and anti-inflammatory signals. |
| References | Schafer, Peter. “Apremilast Mechanism of Action and Application to Psoriasis and Psoriatic Arthritis.” Biochemical Pharmacology, vol. 83, no. 12, June 2012, pp. 1583–90, https://doi.org/10.1016/j.bcp.2012.01.001. |
